76 related articles for article (PubMed ID: 12351407)
1. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.
Lim MS; Adamson A; Lin Z; Perez-Ordonez B; Jordan RC; Tripp S; Perkins SL; Elenitoba-Johnson KS
Blood; 2002 Oct; 100(8):2950-6. PubMed ID: 12351407
[TBL] [Abstract][Full Text] [Related]
2. Proliferation in HHV-8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1).
Carbone A; Gloghini A; Bontempo D; Monini P; Tirelli U; Volpe R; Browning PJ; Gaidano G
Am J Pathol; 2000 Apr; 156(4):1209-15. PubMed ID: 10751346
[TBL] [Abstract][Full Text] [Related]
3. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells.
Lu L; Schulz H; Wolf DA
BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931
[TBL] [Abstract][Full Text] [Related]
4. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression.
Kossatz U; Dietrich N; Zender L; Buer J; Manns MP; Malek NP
Genes Dev; 2004 Nov; 18(21):2602-7. PubMed ID: 15520280
[TBL] [Abstract][Full Text] [Related]
5. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis.
Hwang HC; Martins CP; Bronkhorst Y; Randel E; Berns A; Fero M; Clurman BE
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11293-8. PubMed ID: 12151601
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.
Kudoh S; Kumaravel TS; Kuramavel B; Eguchi M; Asaoku H; Dohy H; Fujiwara M; Sasaki N; Tanaka K; Kamada N
Jpn J Cancer Res; 1999 Nov; 90(11):1262-9. PubMed ID: 10622539
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.
Lin Z; Lim S; Viani MA; Sapp M; Lim MS
Am J Pathol; 2001 Aug; 159(2):711-9. PubMed ID: 11485929
[TBL] [Abstract][Full Text] [Related]
8. Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.
Zhuang M; Li F; Liang H; Su Y; Cheng L; Lin B; Zhou J; Deng R; Chen L; Lyu P; Lu Z
Cell Death Dis; 2024 Apr; 15(4):241. PubMed ID: 38561375
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 intrinsically promotes the proliferation of breast cancer cells through the SKP2-p27/p21 axis.
Elfoly M; Mirza JY; Alaiya A; Al-Hazzani AA; Tulbah A; Al-Alwan M; Ghebeh H
Cancer Cell Int; 2024 May; 24(1):161. PubMed ID: 38725021
[TBL] [Abstract][Full Text] [Related]
10. Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies.
Kratzat S; Nikolova V; Miething C; Hoellein A; Schoeffmann S; Gorka O; Pietschmann E; Illert AL; Ruland J; Peschel C; Nilsson J; Duyster J; Keller U
PLoS One; 2012; 7(5):e37433. PubMed ID: 22624029
[TBL] [Abstract][Full Text] [Related]
11. Impaired germ cell development due to compromised cell cycle progression in Skp2-deficient mice.
Fotovati A; Nakayama K; Nakayama KI
Cell Div; 2006 Apr; 1():4. PubMed ID: 16759351
[TBL] [Abstract][Full Text] [Related]
12. N-Myc transcriptionally activates Skp2 to suppress p27 expression in small cell lung cancer.
Zou J; Lin Y; Hu M; Wan M; Tan X; Xu X; Xu F
Pathol Res Pract; 2022 Oct; 238():154083. PubMed ID: 36027654
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC-01572:28 inhibits granulosa cell growth via a decrease in p27 (Kip1) degradation in patients with polycystic ovary syndrome.
Zhao J; Xu J; Wang W; Zhao H; Liu H; Liu X; Liu J; Sun Y; Dunaif A; Du Y; Chen ZJ
EBioMedicine; 2018 Oct; 36():526-538. PubMed ID: 30293818
[TBL] [Abstract][Full Text] [Related]
14. SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies.
William JNG; Dhar R; Gundamaraju R; Sahoo OS; Pethusamy K; Raj AFPAM; Ramasamy S; Alqahtani MS; Abbas M; Karmakar S
Front Oncol; 2024; 14():1288501. PubMed ID: 38559562
[TBL] [Abstract][Full Text] [Related]
15. The miR-106a~363
Kuppers DA; Schmitt TM; Hwang HC; Samraj L; Clurman BE; Fero ML
Oncotarget; 2017 Aug; 8(31):50680-50691. PubMed ID: 28881594
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer.
Rezaeian AH; Phan LM; Zhou X; Wei W; Inuzuka H
Neoplasia; 2023 Apr; 38():100890. PubMed ID: 36871351
[TBL] [Abstract][Full Text] [Related]
17. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
18. The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia.
Hodeib H; Abd El Hai D; Tawfik MA; Allam AA; Selim AF; Sarhan ME; Selim A; Sabry NM; Mansour W; Youssef A
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741710
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Activation of MYC-Induced Genes by GCN5 Promotes B-cell Lymphomagenesis.
Farria AT; Plummer JB; Salinger AP; Shen J; Lin K; Lu Y; McBride KM; Koutelou E; Dent SYR
Cancer Res; 2020 Dec; 80(24):5543-5553. PubMed ID: 33168647
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib.
Chen X; Huang Z; Wu W; Xia R
Cancer Manag Res; 2020; 12():4777-4787. PubMed ID: 32606967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
